Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III study of M606102 (glycopyrronium tosylate) in primary axillary hyperhidrosis
jRCT2080224742Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of glycopyrronium tosylate in essential axillary hyperhidrosis (2 arms), sponsored by Maruho Co., Ltd. Started Jun 2019; status: completed.
02
Drugs
glycopyrronium tosylate
03
Conditions
essential axillary hyperhidrosis
Beyond the preview
Go deeper on jRCT2080224742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224742.